Cierra Harden PharmD Candidate 2013 LECOM School of Pharmacy, Bradenton Obesity is a major risk factor for the development of diabetes as well as predisposing individuals to hypertension and dyslipidemia. In the United States, 54.8% of persons with diabetes are obese, and 85.2% are overweight or obese1. All of these …
Read More »The Use of GLP-1 Analogs and Lifestyle Changes
Alan Mathis PharmD Candidate 2013 University of Florida GLP-1 analogs not only improve plasma glucose levels and reduce HbA1c, but also improve metabolic effects such as reduction in BMI, waist circumference, and improve cardiovascular health. Diabetic patients, especially with type 2 diabetes, tend to have poor diets and sedentary lifestyle …
Read More »GLP-1 Agonists and Lifestyle Changes: A Recipe for Success
Andre McMahon, PharmD Candidate UF College of Pharmacy Achieving glycemic control is a critical goal in the management of patients with type 2 diabetes mellitus (DM). Hyperglycemia contributes to the progression of DM by adversely affecting both the body’s sensitivity to insulin and beta-cell function. Type 2 DM results from …
Read More »Psoriasis Increases Risk of Diabetes
A new study of the entire Danish population confirms previous reports of increased risk of diabetes mellitus in patients with psoriasis, and shows the risk increases with the severity of psoriasis….
Read More »Screening for Pre-diabetes Works
The use of A1c plus FPG had the best performance in reducing the likelihood of missing future cases of diabetes….
Read More »Walking after Eating Lowers Glucose in Healthy People and Diabetes Patients
Walking or other light exercise after meals may reduce glucose levels by more than half in both healthy people and type 1 diabetes patients….
Read More »Diabetes Increases Risk of Cardiovasular Events by 30%
Diabetes was associated with a 30% increased risk of developing cardiovascular conditions, including heart disease and stroke….
Read More »Gastric Emptying Remains Stable over Time for Type 1 and Type 2 Diabetes
Gastric emptying of solids and liquids, and gastrointestinal symptoms remain stable over time in patients with long-term type 1 and type 2 diabetes….
Read More »Aliskiren No Help for Type 2 Patients
The ALTITUDE trial, which was prematurely halted, showed that when added to monotherapy with either an ACE inhibitor or an ARB, aliskiren (Tekturna) did not improve outcomes in patients with type 2 diabetes who had high cardiovascular and renal risk….
Read More »Dramatic Benefits in Diabetes for Small Blood Pressure Drops to Below Normal
Even normotensive patients with diabetes can reduce their risk of heart attack, stroke, and renal failure by lowering blood pressure….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.